This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …

The harmful use of alcohol has been estimated to cause approximately 3.3 million deaths
every year, corresponding to nearly 6% of all deaths globally. Therefore, the effective …

The diagnostic assessment of liver injury is an important step in the management of patients
with chronic liver disease (CLD). Although liver biopsy is the reference standard for the …

Background & Aims Magnetic resonance elastography (MRE) and transient elastography
(TE) are noninvasive techniques for detection of liver fibrosis. Single-center studies have …

Nonalcoholic fatty liver disease (NAFLD) is a global pandemic that affects one-quarter of the
world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to …

Background & Aims Studies have produced conflicting results of the incidence of
hepatocellular carcinoma (HCC) in patients with hepatitis C virus–associated cirrhosis …

Patients with compensated advanced chronic liver disease (cACLD) can safely avoid
screening endoscopy with a platelet count> 150× 109 cells/L and a liver stiffness …

Background & Aims Liver fibrosis is the main determinant of long-term outcome in chronic
liver diseases. Little is known about the prevalence of liver fibrosis in the general population …

Hepatitis C virus (HCV) infection and its complications have been the major cause of
cirrhosis and its complications for several decades in the Western world. Until recently …

Inhibitors of programmed cell death 1 (PD‐1) administered as single agents have resulted in
durable tumor regression in advanced cancer patients. However, only a minority of cancer …